A Rho exchange factor mediates fMet-Leu-Phe-induced NF-kappaB activation in human peripheral blood monocytes

Area of Science:

• Cellular and Molecular Immunology
• Signal Transduction Pathways
• G-Protein Coupled Receptor Signaling

Background:

• Formyl-methionyl-leucyl-phenylalanine (fMLP) is a bacterial product that stimulates NF-kappaB activation in human peripheral blood monocytes.
• This fMLP-induced NF-kappaB activation is known to require the small GTPase RhoA.

Purpose of the Study:

• To investigate the specific role of the guanine nucleotide exchange factor Lbc in RhoA-mediated NF-kappaB activation.
• To elucidate the mechanism by which Lbc influences RhoA activity and subsequent signaling.

Main Methods:

• Co-immunoprecipitation to assess the association between RhoA and Lbc.
• Guanine nucleotide exchange assays to determine Lbc's catalytic activity on RhoA.
• Reporter gene assays in THP1 cells to measure NF-kappaB-mediated gene expression.
• Inhibition studies using C3 transferase (RhoA inhibitor) and a dominant-negative RhoA mutant (T19N).

Main Results:

• RhoA was found to specifically associate with Lbc in fMLP-stimulated human peripheral blood monocytes.
• Lbc was demonstrated to specifically catalyze the guanine nucleotide exchange activity of RhoA.
• Cotransfection of Lbc in THP1 cells significantly increased NF-kappaB-mediated reporter gene expression.
• This Lbc-enhanced NF-kappaB activation was inhibited by both a RhoA inhibitor and a dominant-negative RhoA mutant.

Conclusions:

• Guanine nucleotide exchange factor Lbc is a novel signal transducer in the pathway of RhoA-mediated NF-kappaB activation.
• Lbc plays a critical role in initiating RhoA signaling in response to bacterial products like fMLP.
• Understanding this Lbc-RhoA-NF-kappaB axis provides insights into innate immune responses.